De Pasquale, B., Righetti, G., and Menotti, A
This matters because counterfeit weight loss medications are a real problem in Nigeria
Volume is typically 0.1 mL with an insulin syringe
Tirzepatide is a once-weekly, dual-incretin peptide it activates both the GIP and the GLP-1 receptor from a single molecule and in published obesity trials it has produced some of the largest average weight reductions of any incretin agent studied to date
The more effective oral medicines we have to help people with type 2 diabetes lose weight and keep it off, the better. He added that holistic approaches targeting weight, blood sugar, and cardiovascular risk simultaneously are likely to deliver the greatest benefits for people with type 2 diabetes